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Pursuant to a Continuing Budget Resolution signed into law May 18, 2020, the South Carolina 
General Assembly and Governor Henry McMaster have called upon the Department of 
Health and Environmental Control (DHEC), the Medical University of South Carolina (MUSC), 
and the South Carolina Hospital Association (SCHA) to develop and implement a statewide 
testing plan for the novel coronavirus designated as COVID-19. Since the virus was first 
identified in the Palmetto State, DHEC, MUSC and other organizations have screened and 
tested thousands of individuals, and the pace of testing continues to increase.  
Objectives of the Statewide Testing Plan. Testing is critical to prevent spread of the virus 
by informing treatment protocols, addressing hotspots, and tracking progression of the virus. 
In order to transition safely back to our normal lifestyles, South Carolina needs to increase per 
capita testing to allow for more precise public health interventions. The federal government 
has committed to deliver testing supplies, provided DHEC and its partners test at least two 
percent (2%) of the state’s population each month. That equates to 110,000 tests performed 
per month, and this statewide plan aims to meet or exceed that target.  
Central Coordination, Decentralized Implementation. In order to better align statewide 
testing efforts, DHEC, MUSC and SCHA have established a coordination team to standardize 
specimen collection protocols, develop public education materials, coordinate test results, 
and establish a system to ensure follow-up care for individuals who do not have primary care 
homes. This coordination team will also monitor emerging hotspots and marshal resources to 
address them expeditiously. 
DHEC, MUSC and SCHA will oversee the plan through the coordination team, but 
implementation will be decentralized in DHEC’s four regions (Upstate, Midlands, Pee Dee 
and Lowcountry). The Department’s four Regional Health Directors will serve as conveners for 
their regions of the state, and MUSC and SCHA will each assign regional contacts to work in 
partnership with those Regional Health Directors. All partners (hospitals, Rural Health Clinics, 
Community Health Centers, etc.) will work through the teams led by DHEC’s Regional Health 
Directors to establish testing sites, schedules, supplies, and follow-up.  
What Type of Test Will Be Used? Generally speaking, two approaches to testing are 
currently available: diagnostic testing and antibody testing. Diagnostic testing identifies the 
presence of COVID-19 and is used primarily for people who have symptoms commonly 
associated with the virus. Antibody testing helps determine if an individual has been exposed 
to COVID-19 in the past and might have developed immunity to the virus. Antibody testing is 
not reliable as a test for active disease, so the initial statewide testing plan will rely on 
diagnostic testing to identify active disease in the state. However, effective antibody tests may 
help determine the prevalence of previous COVID exposure in South Carolina so this plan 




Determining Whom and Where to Test. The authorizing legislation specifically calls for 
testing in rural communities and communities with a high prevalence of COVID-19 and/or 
with demographic characteristics consistent with risk factors for COVID-19 including, but not 
limited to, communities with higher proportions of seniors, African Americans, or individuals 
with chronic lung disease, asthma, serious heart conditions, severe obesity, compromised 
immune systems, diabetes, liver disease, or who are on dialysis. In order to achieve these 
important testing goals, we have established the following principles to guide our work. 
• Congregate Living Facilities. COVID-19 outbreaks at long term care and corrections 
facilities indicate ongoing transmission of virus within a community and require an 
intense focus on infection prevention practices. Nursing home populations are of 
particular concern because residents with chronic medical conditions are at highest 
risk for complications or death from infection. To help protect this vulnerable 
population, DHEC has already begun universal testing of all 40,000 South 
Carolina nursing home residents and staff. This initial focus on nursing homes will 
be complete by the end of May, and the effort to address congregate living facilities 
will continue with prisons, jails, assisted living facilities and group homes. 
 
• Under-Resourced Minority and Rural Communities. African American, Hispanic, 
and Native American populations have been disproportionately impacted by COVID-
19, with higher per capita rates of serious illness and death than in white populations. 
The Centers for Disease Control and Prevention (CDC) identified counties that could 
benefit from testing using indicators such as percentage of the population living in 
poverty, community testing rates, and rurality. DHEC regional staff prioritized 
additional communities for testing based on limited access to healthcare, elevated 
rates of chronic disease, and poor health outcomes. Testing will be increased in these 
communities using mobile specimen collection, community paramedicine testing, and 
fixed testing sites. 
 
• Urban Areas of the State. Urban areas are at risk for ongoing transmission of COVID-
19 due to their size, population density, and access to many social venues where people 
congregate. Urban centers also are centers of tourism and commerce, welcoming 
domestic and international visitors. DHEC is already working with partners to host pop-
up testing events at multiple locations each month in Charleston, Columbia, and the 
Greenville/Spartanburg areas. 
Other cities of concern for introduction and rapid transmission of virus are those that 
attract large numbers of tourists, such as Myrtle Beach. Cities bordering states that have 
not used a phased approach to reopening are also at risk for COVID-19 transmission, 
such as Aiken and North Augusta. Open testing events in these communities will help 




• Symptomatic versus Asymptomatic Individuals. Researchers estimate that as many 
as 50% of all persons infected with COVID-19 do not have any symptoms of illness. 
Nevertheless, because testing supplies were limited in the early months of the COVID-
19 response the only individuals prioritized for testing were those with symptoms of 
the virus. Now that testing supplies are more plentiful, we want to make COVID-19 
testing available to any person, whether or not they have symptoms. 
• Unexpected Deaths Investigated by a Coroner. Reports of individuals with unknown 
COVID-19 infection status who died alone at home raise the concern for unrecognized 
and unreported deaths due to the virus. In order to fully understand the impact of this 
virus on the number of people dying in our state, DHEC has updated its guidance for 
coroners and medical examiners to encourage testing of individuals who died 
unexpectedly. DHEC will distribute test kits to coroners throughout the state to use in 
post-mortem testing of patients who die unexpectedly regardless of symptoms or with 
symptoms of COVID-19 without a positive test. Positive test results will be followed by 
contact tracing with family of the deceased.  
 
• Fixed Locations, Mobile Specimen Collection, and Pop-up Sites. The best 
approach to testing sites will likely be a mix of fixed locations, mobile specimen 
collection, using pop-up sites, and rapid response teams to respond quickly to  
emerging hotspots. MUSC will work with DHEC Regional Health Directors to offer all 
types of specimen collection sites for deployment across the state. In addition, SCHA 
will assist MUSC and DHEC to recruit regional hospital partners to assist with testing.   
 
Critical Sectors of the South Carolina Economy. As statewide testing accelerates, there are 
critical sectors of the state’s economy that need to be advised and supported so they can 
regain their pre-COVID strength. These include K-12 education, colleges and universities, 
manufacturing, tourism, and many other businesses that will likely have questions about 
testing their employees and customers. The CDC published guidance for state testing 
prioritizes public health testing of the healthcare workforce, individuals with symptoms, 
communities at high risk for serious complications or death from COVID-19 or surveillance 
testing in communities to understand disease transmission.  CDC does not currently include a 
public health role for routine testing in academic or business settings. An Interim Guidance 
for Businesses and Employers  document is also available and includes current best practices 
for returning to the workplace.  The U.S. Chamber of Commerce addresses the issue of 
workforce testing in its document, Implementing a National Return to Work Plan. In that 
document, they state:  
 
“To the extent that return to work is based on the testing of employees either for the 
COVID-19 virus or antibodies to COVID-19, there will have to be sufficient testing 
capacity, as well as clear resolution on who is responsible for administering the tests, 




to administer these medical tests, so there must be widely accessible third-party 
providers. There also will need to be standardization as to when employees need to 
be tested, the frequency of tests (especially important if testing for infection, rather 
than antibodies), and the documentation employees will provide to employers. 
Frequent testing could be especially costly, and it should be determined who will bear 
those costs.” 
 
Appropriate Follow-up. One of the essential elements of this statewide testing plan is our 
commitment to provide timely follow-up care to all individuals who need it. First and 
foremost, persons who submit specimens for testing need to know how to get their test 
results. Individuals who test positive for COVID-19 need to know how and where to seek 
treatment for the virus, and they also need to know who will pay for their medical care. 
Individuals who do not currently have a primary care home will be offered a referral 
regardless of whether they test positive or negative for the virus. This is an important 
opportunity to help underserved South Carolinians establish a medical home and thereby 
improve their health.  
Case Management and Prevention of Ongoing Transmission (Contact Tracing). In 
addition to a referral for follow-up medical care, guidance for staying well and preventing 
transmission to family and friends with be provided by DHEC for all persons who test positive 
for COVID-19.   
Contact tracing is a standard disease control measure that has long been used by public 
health professionals to help people get the medical care they need and prevent further 
spread of disease within a community.  The mission of contact tracing is to ensure that people 
who are unknowingly exposed to a contagious individual are provided education regarding 
the next steps and how to seek testing if indicated. Specifically, it is the process of talking to  
those who have tested positive for the virus, asking them about anyone who they have had 
close contact with and connecting with those close contacts to provide guidance to help 
them recognize the symptoms of COVID-19 so they can seek medical care, if needed, while 
educating them about the importance of quarantine to limit the spread of the disease to their 
family and friends. This extensive contact tracing process helps interrupt  transmission of the 
disease within a community. 
 
Contact tracing isn't new to South Carolina or to DHEC. During normal operations DHEC has 
approximately 20 contact tracers who perform this methodology to help limit the spread of 
diseases like HIV, tuberculosis, and hepatitis by educating people about the disease and how 
to prevent its spread and connecting them to the medical care they need.  As part of the 
COVID-19 response, DHEC has surged its contact tracers from 20 to 400 and has identified 
more than 1,000 volunteer and contract staff ready to receive training. DHEC has been 
performing contact tracing throughout the pandemic response and will continue to perform 





It is critical that public health staff notify the exposed individuals of their potential exposure as 
rapidly and sensitively as possible. To protect patient privacy, contacts are only informed that 
they may have been exposed to a patient with the virus. DHEC staff do not share the identity 
of the patient who may have exposed the contact.   
 
Prioritization of Testing Supplies. One of the greatest challenges in the early phases of our 
state’s response to COVID-19 was the shortage of testing supplies. Specimen collection kits, 
testing instruments, and laboratory supplies are all essential to perform COVID-19 testing, 
and each of these has been in short supply at one time or another. The CDC and DHEC 
wisely established a testing priority list to ensure hospital inpatients, symptomatic healthcare 
workers, and symptomatic first responders would have access to diagnostic testing as our 
state’s highest priorities. Other categories follow in priority order, and only recently has South 
Carolina enjoyed sufficient testing capacity to begin widespread testing of asymptomatic 
individuals. This statewide plan seeks to test as many South Carolinians as possible, but we 
will revert to the CDC/DHEC prioritization system in the event testing supplies once again 
become scarce. 
Community Outreach. Communication is a critical but challenging component to reaching 
rural and underserved communities, given disparities in access to a reliable broadband 
connection and transportation. MUSC, DHEC and SCHA will work with other partners to 
identify gaps in existing outreach and deliver information and care directly to rural residents 
of the state. Notable examples include collaboration with Clemson University’s “Healthy Me—
Healthy SC” partnership, the Hospital Association, Community Health Centers, the South 
Carolina Telehealth Alliance, and the South Carolina Office of Rural Health.  
Getting Involved. Organizations that want to participate as partners in this testing plan are 
invited to do so by contacting one of the testing coordinators listed below. 
DHEC Testing Coordinator:  
MUSC Testing Coordinator:  
SCHA Testing Coordinator:  
Authorizing Legislation 
The Medical University of South Carolina, in consultation with the Department of Health and 
Environmental Control and the South Carolina Hospital Association, shall develop and 
deploy a statewide COVID-19 testing plan within ten days of the effective date of this act. The 
plan must emphasize testing in rural communities and communities with a high prevalence of 
COVID-19 and/or with demographic characteristics consistent with risk factors for COVID-19 
including, but not limited to, communities with higher proportions of seniors, African 
Americans, or individuals with chronic lung disease, asthma, serious heart conditions, severe 
obesity, compromised immune systems, diabetes, liver disease, or who are on dialysis. 
Section 3(C)(1) of Act No. 135, Ratified May 12, 2020, and Signed by the Governor May 18, 
2020. 
